Last reviewed · How we verify

NCT07205042: WHT

Walking for Hypothyroidism Trial (WHT)

Not yet recruiting NA Last updated 3 October 2025
What this trial tests

NA trial testing Supervised Walking Program in Hypothyroidism in 120 participants. Not yet recruiting.

Timeline
1 November 2025
Primary endpoint
30 April 2026
30 June 2026

Quick facts

Lead sponsorUniversity of Karachi
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposesupportive care
Enrollment120
Start date1 November 2025
Primary completion30 April 2026
Estimated completion30 June 2026
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

University of Karachi

Who can join

Adults 35 to 55, female only, with Hypothyroidism. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Women with hypothyroidism often report persistent fatigue, weight gain, autonomic dysregulation, and stress despite stable levothyroxine therapy. This single-center, parallel-group RCT will test whether a structured, supervised 12-week walking program improves basal metabolic rate (BMR) and psychophysiological outcomes compared with usual activity. One hundred twenty women aged 35-55 with stable primary hypothyroidism will be randomized 1:1 to intervention or control.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Hypothyroidism

Currently open trials in the same condition.

Other University of Karachi trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07205042.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing